BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI)

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI)


Share Price
$ 3.73
Change
0.01 (0.27 %)
Market Cap
$80.95 m
Proactive Investors - Run By Investors For Investors

BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as: Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease and Motor Neuron Disease), Multiple Sclerosis, Parkinson’s Disease and Huntington’s Disease

EPIC: BCLI
Market: NASDAQ:BCLI
52-week High/Low: $4.44 / $2.95
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $80.95 m
Website: www.brainstorm-cell.com
col 3
col 4
col 5
col 6

BrainStorm Cell Therapeutics Inc. Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use